clopidogrel has been researched along with Debility in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Bessette, LG; Cervone, A; Cheng, S; Glynn, RJ; Kim, DH; Ko, D; Lee, SB; Lin, KJ; Pande, A | 1 |
Bell, JS; Farinola, N; Hauta-Aho, M; Huupponen, R; Johns, S; Korhonen, MJ; Shakib, S; Teperi, S | 1 |
Alexander, KP; Armstrong, PW; Clemmensen, P; Fox, KA; Goodman, SG; Hochman, JS; Kaul, P; Ohman, EM; Prabhakaran, D; Roe, MT; Savu, A; White, HD | 1 |
1 trial(s) available for clopidogrel and Debility
Article | Year |
---|---|
Sex And Prognostic Significance of Self-Reported Frailty in Non-ST-Segment Elevation Acute Coronary Syndromes: Insights From the TRILOGY ACS Trial.
Topics: Acute Coronary Syndrome; Aged; Aging; Clopidogrel; Comorbidity; Exercise; Female; Frailty; Hand Strength; Humans; Male; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prevalence; Prognosis; Self Report; Sex Factors; Walking Speed | 2019 |
2 other study(ies) available for clopidogrel and Debility
Article | Year |
---|---|
Utilization of P2Y
Topics: Aged; Clopidogrel; Female; Frailty; Humans; Male; Medicare; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Retrospective Studies; ST Elevation Myocardial Infarction; Ticagrelor; Treatment Outcome; United States | 2023 |
Frailty and Co-Prescribing of Potentially Interacting Drugs in New Users of Warfarin.
Topics: Acetaminophen; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Clopidogrel; Drug Interactions; Drug Prescriptions; Drug Utilization Review; Female; Frail Elderly; Frailty; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Warfarin | 2020 |